StockData
CalciMedica, Inc. logo

CalciMedica, Inc. (CALC) stock

CALCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 1/30
$1.22+0.03 (+2.52%)

Close on Nov 17, 2026Market cap $41.65MP/E –Yield –

CalciMedica ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

CalciMedica's ebitda for the twelve months ending Dec 31, 2023 was -$38.02M. For fiscal 2023 it was -$38.02M.

Annual ebitda

PeriodPeriod endValueChange
FY2023Dec 31, 2023-$38.02M–
FY2022Dec 31, 2022-$14.14M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023-$4.30M–
Q3 FY2023Sep 30, 2023-$4.82M–
Q2 FY2023Jun 30, 2023-$6.57M–
Q1 FY2023Mar 31, 2023-$22.33M–
Q2 FY2022Jun 30, 2022-$3.58M–
Q1 FY2022Mar 31, 2022-$4.20M–

More CalciMedica figures

See a number that looks wrong?